Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Penka

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Circulating Plasma Cells in Monoclonal GammopathiesR Bezdekova, M Penka, R Hájek, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1992
Protein C and hypertensionM Penka, M Parizek, S Cronberg, et al.
Ceskoslovenska Pediatrie|April 1, 1990
[Thrombocytopenia and thrombocytopathy in neonates and infants]D Brolíková, M Bĕlusa, M Bajer, et al.
Vnitrni Lekarstvi|March 16, 2004
[Successful treatment of chronic hepatitis C in hemophiliacs based on historical development of therapeutic protocols]P Husa, P Smejkal, L Husová, et al.
Vnitrni Lekarstvi|January 1, 1997
[A new purine analog in the treatment of hematologic malignancy. I. Fludarabine]I Vásová, M Penka, R Hájek, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 23, 2008
[Comparison of dendritic cells antigens in healthy volunteers and monoclonal gammopathy of undetermined significance and/or multiple myeloma patients]L Kovárová, J Michálek, M Kýr, et al.
Vnitrni Lekarstvi|April 28, 2006
[Prevention of venous thromboembolism in internal medicine and neurology]J Malý, P Dulícek, M Penka, et al.
Vnitrni Lekarstvi|April 19, 2011
[Thrombohaemorrhagic syndrome in patients with a myeloproliferative disease with thrombocythemia]M Penka, J Kissová, A Buliková, et al.
Vnitrni Lekarstvi|April 3, 2012
[Significance of urokinase and its inhibitors in the invasiveness and metastasing of malignant tumors]J Halámková, I Kiss, J Tomášek, et al.
Vnitrni Lekarstvi|August 1, 1985
[Platelet alpha2-adrenergic receptors in essential hypertension. Number of binding sites, cyclic adenosine monophosphate and platelet aggregation]P Prikryl, K Rysánek, V Vondrácek, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Circulating Plasma Cells in Monoclonal GammopathiesR Bezdekova, M Penka, R Hájek, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1992
Protein C and hypertensionM Penka, M Parizek, S Cronberg, et al.
Ceskoslovenska Pediatrie|April 1, 1990
[Thrombocytopenia and thrombocytopathy in neonates and infants]D Brolíková, M Bĕlusa, M Bajer, et al.
Vnitrni Lekarstvi|March 16, 2004
[Successful treatment of chronic hepatitis C in hemophiliacs based on historical development of therapeutic protocols]P Husa, P Smejkal, L Husová, et al.
Vnitrni Lekarstvi|January 1, 1997
[A new purine analog in the treatment of hematologic malignancy. I. Fludarabine]I Vásová, M Penka, R Hájek, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 23, 2008
[Comparison of dendritic cells antigens in healthy volunteers and monoclonal gammopathy of undetermined significance and/or multiple myeloma patients]L Kovárová, J Michálek, M Kýr, et al.
Vnitrni Lekarstvi|April 28, 2006
[Prevention of venous thromboembolism in internal medicine and neurology]J Malý, P Dulícek, M Penka, et al.
Vnitrni Lekarstvi|April 19, 2011
[Thrombohaemorrhagic syndrome in patients with a myeloproliferative disease with thrombocythemia]M Penka, J Kissová, A Buliková, et al.
Vnitrni Lekarstvi|April 3, 2012
[Significance of urokinase and its inhibitors in the invasiveness and metastasing of malignant tumors]J Halámková, I Kiss, J Tomášek, et al.
Vnitrni Lekarstvi|August 1, 1985
[Platelet alpha2-adrenergic receptors in essential hypertension. Number of binding sites, cyclic adenosine monophosphate and platelet aggregation]P Prikryl, K Rysánek, V Vondrácek, et al.
Pageof 11